After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
CBI interrogates former NSE MD Chitra Ramakrishna, it is a matter of deciding Baba's influence
Chitra Ramakrishna, former MD of NSE, is getting into trouble after the SEBI report. The Central
These days, many areas of the country are suffering from scorching heat. The hottest day of
India remains at the top of the world's top 12 countries amid the ever-increasing challenge on th
An exciting match was played in the Vijay Hazare Trophy 2023 on Tuesday, in which Himachal Prades
Grain storage infrastructure in five states including Uttar Pradesh will soon be equipped with st
Creativity is found walking on the path of life. On Friday morning, the director of a ministry as
Captain Miller Trailer Released: Dhanush is an actor of South cinema, who is known for his explos
In the Nikki death case that took place in the Thana Kasna area of Greater Noida in Gautam
Paris Olympics 2024 has been in the news for many reasons. From the controversy over 'The Last Su
Doomed Pakistan will get help: IMF agreed to increase relief package, loan will be made 8 billion
There is a ray of hope for Pakistan, which has sunk into the quagmire of debt. The International
